---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-000446"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2021-07-12T23:59:59+00:00"
generated_at: "2026-06-30T06:10:39.536984+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# agilon health appoints Karen McLoughlin to board of directors

## Summary
- Board increased to 11 directors; McLoughlin elected Class II director effective July 12, 2021.
- McLoughlin served as CFO of Cognizant (2012-2020), overseeing growth from ~$365M to ~$17B revenue.
- She was also named to the audit committee; currently serves on Best Buy's board.

## SEC filing metadata
- accession: 0000950170-21-000446
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2021-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017021000446/0000950170-21-000446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017021000446/agl-20210709.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-000446
- JSON: https://secwatch.observer/filing/0000950170-21-000446.json
- Plain text: https://secwatch.observer/filing/0000950170-21-000446.txt

## Key facts
- Executive change
  Karen McLoughlin was elected as Class II Director at agilon health, inc..
  - Action: elected
  - Role: Class II Director
  source text: Karen McLoughlin was elected to the Board as a Class II director in accordance with the Company’s amended and restated certificate of incorporation, effective as of July 12, 2021, to fill the vacancy on the Board created by the increase in Board size.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000095017021000446/0000950170-21-000446-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.